Sen. Tommy Tuberville (R-AL) disclosed the sale of shares in Pfizer, Inc. (NYSE: PFE) valued between $15,001 and $50,000, according to a filing made public on July 16, 2026. The transaction occurred on June 8, 2026. Under the Stop Trading on Congressional Knowledge (STOCK Act), members of Congress are required to report qualifying financial transactions within 45 days, with amounts disclosed in ranges rather than exact figures.
Tuberville serves on the Senate Committee on Health, Education, Labor, and Pensions (HELP), which holds legislative and oversight jurisdiction over issues relevant to the pharmaceutical industry. Pfizer is one of the world's largest pharmaceutical manufacturers. The disclosure does not indicate the reason for the sale or whether the transaction was executed through a brokerage, advisor, or other arrangement.
Leave a Comment